The Commission on Cancer (CoC), which accredits more than 1500 cancer programs in the US, is a consortium of professional organizations dedicated to improving survival and quality of life for patients with cancer by establishing standards to ensure quality, multidisciplinary, and comprehensive cancer care delivery. As the key engine of quality improvement (QI) within cancer care in the US, the CoC collects, monitors, and reports data on quality of cancer care measures for a variety of cancers including bladder, breast, cervical, colon, endometrial, gastric, kidney, non-small cell lung, ovarian, and rectal cancer. However, despite the QI work of experts in the field of head and neck oncology over the past 20 years, the field of head and neck oncology remained on the CoC Quality Metric sidelines.